DSIP

Overview

What is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from rabbit brain, studied since the 1970s for its role in slow-wave sleep regulation. Human clinical trials, primarily from the 1980s, examined DSIP's effects on sleep quality and duration in chronic insomniacs, with mixed results across studies. More recent preclinical research has examined its neuroprotective properties in stroke recovery models.

• Sleep Support
• Stress Recovery
• Relaxation
• Neuroprotective Research

What the research reports

Reported benefits of DSIP

Outcomes described across the published DSIP literature and ongoing study. Read each as research context rather than a promised personal result.

1. 01

   Sleep architecture research

   Studied for effects on delta wave sleep and sleep structure, which is the origin of the peptide's name and its research interest. Reported in research settings.

2. 02

   Short half-life exposure note

   The 15 minute half-life means exposure is brief, which also explains why effects are reported as inconsistent across studies. Reported in research settings.

3. 03

   Insomnia clinical study work

   Several 1980s and 1990s trials tested it in chronic insomnia, with one reporting improved sleep efficiency and daytime alertness. Reported in research settings.

4. 04

   Stress response study record

   Proposed as a modulator of stress hormones, although a controlled trial found no effect on ACTH or cortisol secretion. Described in the research record.

5. 05

   Historical research value

   The peptide has a long study record from the 1970s onward, useful context even though the field largely moved on. Noted across the published research record.

Clinical evidence

DSIP clinical evidence summary

The published DSIP record, labeled by strength so you can see what is settled and what is still emerging.

Interactions

How DSIP pairs with other peptides

Sedative drugs

No published interaction data. Combining with prescription sleep medicine needs clinical oversight.

Alcohol use

Alcohol disrupts sleep architecture, working against the outcome this peptide is studied for.

Melatonin use

Both are studied for sleep by different mechanisms, with no published data on combined use.

Anaesthetic agents

No independently verified data exists on DSIP and anaesthetic agents. Consult the primary literature before assuming any interaction.